We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+7.53%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.07B
AUM Growth
+$162M
Cap. Flow
+$141M
Cap. Flow %
13.21%
Top 10 Hldgs %
37.33%
Holding
532
New
105
Increased
323
Reduced
47
Closed
36

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$9.31M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$8.32M
3
NVDA icon
NVIDIA
NVDA
+$6.63M
4
MSFT icon
Microsoft
MSFT
+$6.29M
5
UGL icon
ProShares Ultra Gold
UGL
+$5.95M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$5.72M
2
PDD icon
Pinduoduo
PDD
+$4.15M
3
PG icon
Procter & Gamble
PG
+$2.96M
4
SNPS icon
Synopsys
SNPS
+$2.64M
5
AMAT icon
Applied Materials
AMAT
+$2.41M

Sector Composition

Rank Sector Weight
1 Technology 38.03%
2 Healthcare 25.43%
3 Consumer Discretionary 12.38%
4 Communication Services 10.24%
5 Financials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TNGX icon
426
Tango Therapeutics
TNGX
$4.31B
$70.4K 0.01%
22,777
+2,170
+11% +$10.1K
PGEN icon
427
Precigen
PGEN
$2.45B
$69.6K 0.01%
62,099
+6,762
+12% +$5.77K
AQST icon
428
Aquestive Therapeutics
AQST
$531M
$68.8K 0.01%
+19,333
New +$89.2K
SLN
429
Silence Therapeutics
SLN
$641M
$68.5K 0.01%
+9,963
New +$129K
RVNC
430
DELISTED
Revance Therapeutics, Inc.
RVNC
$67.6K 0.01%
22,243
+2,082
+10% +$9.07K
TRVI icon
431
Trevi Therapeutics
TRVI
$2.53B
$67.1K 0.01%
+16,298
New +$52.2K
SLRN
432
DELISTED
ACELYRIN
SLRN
$66.8K 0.01%
21,273
+2,077
+11% +$10.1K
WOLF icon
433
Wolfspeed
WOLF
$1.65B
$66.6K 0.01%
10,000
+5,000
+100% +$51K
VYGR icon
434
Voyager Therapeutics
VYGR
$197M
$65.7K 0.01%
11,583
+1,094
+10% +$7.05K
ABSI icon
435
Absci
ABSI
$1.61B
$63.8K 0.01%
+24,354
New +$85.7K
BZ icon
436
Kanzhun
BZ
$7.19B
$63.5K 0.01%
+4,600
New +$67.7K
RIGL icon
437
Rigel Pharmaceuticals
RIGL
$782M
$62.8K 0.01%
+3,735
New +$71.6K
EL icon
438
Estee Lauder
EL
$31.7B
$62.5K 0.01%
+833
New +$65.8K
IYW icon
439
iShares US Technology ETF
IYW
$25.4B
$60.6K 0.01%
380
+379
+37,900% +$60K
AVIR icon
440
Atea Pharmaceuticals
AVIR
$405M
$60K 0.01%
17,909
+1,672
+10% +$5.56K
ITOS
441
DELISTED
iTeos Therapeutics
ITOS
$59.5K 0.01%
7,747
+723
+10% +$6.21K
VNDA icon
442
Vanda Pharmaceuticals
VNDA
$314M
$59.2K 0.01%
12,363
+1,152
+10% +$5.53K
ACIU icon
443
AC Immune
ACIU
$267M
$56.6K 0.01%
20,970
+1,949
+10% +$6.09K
LXRX icon
444
Lexicon Pharmaceuticals
LXRX
$1.05B
$56.6K 0.01%
76,650
+7,123
+10% +$8.59K
FHTX icon
445
Foghorn Therapeutics
FHTX
$394M
$55.6K 0.01%
+11,788
New +$85.9K
AMLX icon
446
Amylyx Pharmaceuticals
AMLX
$2.6B
$54.9K 0.01%
14,535
+1,441
+11% +$6.78K
FDMT icon
447
4D Molecular Therapeutics
FDMT
$621M
$54.6K 0.01%
9,802
-193
-2% -$1.51K
CCCC icon
448
C4 Therapeutics
CCCC
$480M
$53.9K 0.01%
+14,967
New +$74.4K
LRMR icon
449
Larimar Therapeutics
LRMR
$454M
$52.4K ﹤0.01%
+13,529
New +$89.3K
ARTV
450
Artiva Biotherapeutics
ARTV
$564M
$51.9K ﹤0.01%
+5,150
New +$61.9K
16 17
18
19 20

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q4 2024 Portfolio in Review

As of Q4 2024, China Universal Asset Management Company held 532 positions worth $1.07B, up 18% from $907M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

China Universal Asset Management Company deployed $141M of net new capital in Q4 2024, opening 105 new positions and adding to 323 existing holdings. Its largest new stake was Astera Labs: 26,000 shares worth $3.44M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Pinduoduo, an estimated $4.15M trimmed.

  • China Universal Asset Management Company's largest Q4 2024 buy was Astera Labs: 26,000 shares worth $3.44M.
  • China Universal Asset Management Company added most to Apple in Q4 2024, an estimated $9.31M increase.
  • China Universal Asset Management Company's biggest Q4 2024 reduction was Pinduoduo, cutting an estimated $4.15M.
  • China Universal Asset Management Company fully exited Alibaba in Q4 2024, selling an estimated $5.72M.
  • China Universal Asset Management Company's ten largest holdings make up 37% of its $1.07B portfolio in Q4 2024.
  • China Universal Asset Management Company opened 105 new positions and closed 36 in Q4 2024.
  • China Universal Asset Management Company's portfolio value rose 18% quarter-over-quarter to $1.07B.

Based on China Universal Asset Management Company's 13F filing for Q4 2024, filed 24 Jan 2025.